Literature DB >> 31666730

Modulation of innate and adaptive immunity by cytomegaloviruses.

Richard Berry1,2,3, Gabrielle M Watson4,5,6, Stipan Jonjic7, Mariapia A Degli-Esposti4,8,9, Jamie Rossjohn4,5,6,10.   

Abstract

The coordinated activities of innate and adaptive immunity are critical for effective protection against viruses. To counter this, some viruses have evolved sophisticated strategies to circumvent immune cell recognition. In particular, cytomegaloviruses encode large arsenals of molecules that seek to subvert T cell and natural killer cell function via a remarkable array of mechanisms. Consequently, these 'immunoevasins' play a fundamental role in shaping the nature of the immune system by driving the evolution of new immune receptors and recognition mechanisms. Here, we review the diverse strategies adopted by cytomegaloviruses to target immune pathways and outline the host's response.

Mesh:

Substances:

Year:  2019        PMID: 31666730     DOI: 10.1038/s41577-019-0225-5

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  28 in total

1.  Disarming the Old Foe. Restoring T-Cell Immune Function with mTor-Inhibitors to Tackle Cytomegalovirus Infection.

Authors:  Oriol Bestard; Elena Crespo
Journal:  J Am Soc Nephrol       Date:  2022-01       Impact factor: 10.121

Review 2.  Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.

Authors:  Sara Hamdan; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2022-04-01       Impact factor: 3.402

Review 3.  A guide to antigen processing and presentation.

Authors:  Novalia Pishesha; Thibault J Harmand; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2022-04-13       Impact factor: 53.106

4.  Altered-Self MHC Class I Sensing via Functionally Disparate Paired NK Cell Receptors Counters Murine Cytomegalovirus gp34-Mediated Immune Evasion.

Authors:  John M Cronk; Karolina H Dziewulska; Patryk Puchalski; Rowena B Crittenden; Marie-Louise Hammarskjöld; Michael G Brown
Journal:  J Immunol       Date:  2022-09-07       Impact factor: 5.426

Review 5.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

6.  Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan.

Authors:  Hiroyuki Kondo; Takahiro Kageyama; Shigeru Tanaka; Kunihiro Otsuka; Shin-Ichi Tsukumo; Yoichi Mashimo; Yoshihiro Onouchi; Hiroshi Nakajima; Koji Yasutomo
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 7.  Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications.

Authors:  Raquel Fernández-Moreno; Julián Torre-Cisneros; Sara Cantisán
Journal:  RNA Biol       Date:  2021-05-26       Impact factor: 4.766

8.  Editorial: Cytomegalovirus Pathogenesis and Host Interactions.

Authors:  Emma L Poole; Michael M Nevels
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

9.  Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.

Authors:  Sheng Zhang; Jun Gan; Bao-Guo Chen; Dan Zheng; Jian-Gang Zhang; Rong-Hai Lin; Yi-Ping Zhou; Wei-Ying Yang; Aifen Lin; Wei-Hua Yan
Journal:  Clin Transl Immunology       Date:  2020-05-10

Review 10.  Pathogenesis of human cytomegalovirus in the immunocompromised host.

Authors:  Paul Griffiths; Matthew Reeves
Journal:  Nat Rev Microbiol       Date:  2021-06-24       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.